Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene
2. Sb1317
3. Tg02
1. Sb1317
2. Tg02
3. Tg-02
4. 1204918-72-8
5. Sb-1317
6. 937270-47-8
7. Sb-1317 Free Base
8. (e/z)-zotiraciclib
9. Zotiraciclib [usan]
10. Ex 45
11. Ex45
12. Chembl1944698
13. 40d08182tt
14. Tg02 (sb1317)
15. Zotiraciclib (usan)
16. 20-oxa-5,7,14,27-tetraazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene, 14-methyl-
17. Tg02 (double Bond E)
18. Zotiraciclib [inn]
19. Schembl823947
20. Tg02 [who-dd]
21. Zotiraciclib [who-dd]
22. Gtpl9095
23. Schembl2298965
24. Schembl17595943
25. Unii-40d08182tt
26. Ex-a239
27. Dtxsid601337151
28. 14-methyl-20-oxa-5,7,14,27-tetraazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene
29. Bcp07033
30. Bdbm50363196
31. Mfcd22124499
32. Nsc762673
33. Who 11186
34. Zinc68251500
35. Akos032950000
36. Sb1317(tg-02)
37. Cs-0884
38. Nsc-762673
39. Sb 1317
40. Compound 26h [pmid: 22148278]
41. Ncgc00378999-05
42. 14-methyl-20-oxa-5,7,14,27-tetraazatetracyclo [19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene
43. Ac-33131
44. Ac-35951
45. Bs-14812
46. Bs167349
47. Hy-15166
48. D11599
49. Q27088971
50. (e)-6-methyl-12-oxa-3,6-diaza-2(4,2)-pyrimidina-1,4(1,3)-dibenzenacyclododecaphan-8-ene
51. (6e)-9-methyl-3-oxa-9,12-diaza-1(4,2)-pyrimidina-2,11(1,3)-dibenzenacyclododecaphan-6-ene
52. 14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene
53. 20-oxa-5,7,14,27-tetraazatetracyclo(19.3.1.12,6.18,12)heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene, 14-methyl-, (16e)-
| Molecular Weight | 372.5 g/mol |
|---|---|
| Molecular Formula | C23H24N4O |
| XLogP3 | 4.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 0 |
| Exact Mass | 372.19501140 g/mol |
| Monoisotopic Mass | 372.19501140 g/mol |
| Topological Polar Surface Area | 50.3 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 499 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
62
PharmaCompass offers a list of Zotiraciclib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zotiraciclib manufacturer or Zotiraciclib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zotiraciclib manufacturer or Zotiraciclib supplier.
PharmaCompass also assists you with knowing the Zotiraciclib API Price utilized in the formulation of products. Zotiraciclib API Price is not always fixed or binding as the Zotiraciclib Price is obtained through a variety of data sources. The Zotiraciclib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AKOS032950000 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AKOS032950000, including repackagers and relabelers. The FDA regulates AKOS032950000 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AKOS032950000 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AKOS032950000 supplier is an individual or a company that provides AKOS032950000 active pharmaceutical ingredient (API) or AKOS032950000 finished formulations upon request. The AKOS032950000 suppliers may include AKOS032950000 API manufacturers, exporters, distributors and traders.
AKOS032950000 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AKOS032950000 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AKOS032950000 GMP manufacturer or AKOS032950000 GMP API supplier for your needs.
A AKOS032950000 CoA (Certificate of Analysis) is a formal document that attests to AKOS032950000's compliance with AKOS032950000 specifications and serves as a tool for batch-level quality control.
AKOS032950000 CoA mostly includes findings from lab analyses of a specific batch. For each AKOS032950000 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AKOS032950000 may be tested according to a variety of international standards, such as European Pharmacopoeia (AKOS032950000 EP), AKOS032950000 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AKOS032950000 USP).
